Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Vladimir Potanin donated 500 million rubles ($6.7ml) aimed for creation of smart materials with pre-programmed properties. The project envisages establishment of a brand new Laboratory of Programmable Functional Materials, and will be carried out under the leadership of the Nobel laureate Konstantin Novoselov. More Topics Vladimir Potanin / Interros / Konstantin Novoselov / Tagir Aushev / Human Brain / Fundamental research / physics
18.06.2021
Interros has not applied for the buyback of its Norilsk Nickel shares. As a result of the buyback, Interros share in Norilsk Nickel will increase, which is in line with our long-term strategy.
More Topics Interros / Norilsk Nickel / buyback
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
02.06.2020
The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.
More Topics "Three Volcanoes" Park
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm